Sfoglia per Autore
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation
1995 Lemoli R.M.; Fortuna A.; Fogli M.; Gherlinzoni F.; Rosti G.; Catani L.; Gozzetti A.; Miggiani M.C.; Tura S.
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
2001 Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G.
Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one
2002 Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti G.; Baccarani M.
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
2004 ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE;
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia
2004 BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S.; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
2004 MARTINELLI G; MALAGOLA M; OTTAVIANI E; ROSTI G; TRABACCHI E; BACCARANI M.
Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib
2004 SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M.
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP.
2005 Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; Ottaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G
Leucemia mieloide cronica: terapia molecolare
2005 Rosti G.; Castagnetti F.; Bosi C.; Rondoni M.; Giannoulia P.; Baccarani M.
New tyrosine kinase inhibitors in chronic myeloid leukemia
2005 Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M.
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
2005 BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M.
Does early stem-cell transplantation have a role in chronic myeloid leukaemia? Against the proposal.
2005 Rosti G.; Baccarani M.
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia
2005 Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M.
Dual tyrosine kinase inhibitors in chronic myeloid leukemia.
2005 Martinelli G.; Soverini S.; Rosti G.; Baccarani M.
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia
2006 S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani
Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies
2006 Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.; Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G.
Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies
2006 Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.; Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G.
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia
2006 Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML)
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
2006 IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFUSCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
2006 MARTINELLI G; IACOBUCCI I; ROSTI G; PANE F; AMABILE M; CASTAGNETTI F; CILLONI D; SOVERINI S; TESTONI N; SPECCHIA G; MERANTE S; ZACCARIA A; FRASSONI F; SAGLIO G; BACCARANI M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation | Lemoli R.M.; Fortuna A.; Fogli M.; Gherlinzoni F.; Rosti G.; Catani L.; Gozzetti A.; Miggiani M.C....; Tura S. | 1995-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia | Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici ...S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G. | 2001-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one | Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti ...G.; Baccarani M. | 2002-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Molecular response to imatinib in late chronic-phase chronic myeloid leukemia | ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE... VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE; | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia | BACCARANI M.; MARTINELLI G.; ROSTI G.; TRABACCHI E.; TESTONI N.; BASSI S.; AMABILE M.; SOVERINI S....; CASTAGNETTI F.; CILLONI D.; IZZO B.; DE VIVO A.; MESSA E.; BONIFAZI F.; POERIO A.; LUATTI S.; GIUGLIANO E.; ALBERTI D.; FINCATO G.; RUSSO D.; PANE F.; SAGLIO G.; GIMEMA WORKING PARTY ON CHRONIC MYELOID LEUKEMIA | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. | MARTINELLI G; MALAGOLA M; OTTAVIANI E; ROSTI G; TRABACCHI E; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Denaturing-HPLC-based assay for detection of ABL mutations in Chronic Myeloid Leukemia patients resistant to Imatinib | SOVERINI S; MARTINELLI G.; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M. | 2004-01-01 | CLINICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. | Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; O...ttaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G | 2005-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Leucemia mieloide cronica: terapia molecolare | Rosti G.; Castagnetti F.; Bosi C.; Rondoni M.; Giannoulia P.; Baccarani M. | 2005-01-01 | - | Poletto Editore | 2.01 Capitolo / saggio in libro | - |
| New tyrosine kinase inhibitors in chronic myeloid leukemia | Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. | BONIFAZI F.; BANDINI G.; STANZANI M.; PALANDRI F.; GIANNINI B.; ARPINATI M.; ROSTI G.; BACCARANI M. | 2005-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Does early stem-cell transplantation have a role in chronic myeloid leukaemia? Against the proposal. | Rosti G.; Baccarani M. | 2005-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia | Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagn...etti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M. | 2005-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Dual tyrosine kinase inhibitors in chronic myeloid leukemia. | Martinelli G.; Soverini S.; Rosti G.; Baccarani M. | 2005-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia | S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Ron...doni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies | Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.;... Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G. | 2006-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies | Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.;... Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G. | 2006-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia | Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruz...zese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML) | 2006-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. | IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFU...SCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients | MARTINELLI G; IACOBUCCI I; ROSTI G; PANE F; AMABILE M; CASTAGNETTI F; CILLONI D; SOVERINI S; TEST...ONI N; SPECCHIA G; MERANTE S; ZACCARIA A; FRASSONI F; SAGLIO G; BACCARANI M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile